Active traders looking to bet against biotech stocks have options, including the Direxion Daily S&P Biotech Bear Shares (NYSEArca: LABD) takes the -3x or -300% daily performance of the biotech sector, ProShares UltraPro Short NASDAQ Biotechnology (NasdaqGM: ZBIO) tracks the -3x or -300% daily performance of the Nasdaq Biotechnology Index and ProShares Ultrashort Nasdaq Biotechnology (NasdaqGM: BIS) tracks the -2x or -200% daily performance of the biotech space.
Still, the long-term bull case for biotech and the broader healthcare space is not damaged.
“The growth prospects of the industry remain intact; they are aided by the aging demographic trend that remains irreversible. The fear of additional oversight in my view is unjustified,” adds Seeking Alpha.
For more information on the biotech sector, visit our biotechnology category.
iShares Nasdaq Biotechnology ETF